$29.58
-1.91-6.07%
Last update: Nov 5, 4:01 PM
Cogent Biosciences Inc
COGTNASDAQ
The average analyst price target for Cogent Biosciences is $37.67, 29.0% above the current price. Of 12 analysts, 9 rate it Buy and 3 Hold. Targets range from $9 to $67. The latest change came on Aug 17, 2026, when Piper Sandler raised its price target on Cogent Biosciences from $52 to $55 and kept an Overweight rating.
Price Target Range — 12 Quarters
Analyst Consensus — 12 Analysts
Rating Trend — Last 9 Months
